Table 1: Baseline Characteristics of the Study Population

Control N:30 STEMI N:25 NSTEMI N:16 USAP N:29 SAP N:34 p
Age 54.4±12.5 58.4±9.8 68.1±12.1 59.7±10.8 63.7±9.4 <0.001*
Gender (F/M) 17/13(56%) 5/20(20%) 9/7(56%) 9/20(31%) 14/20(41%) 0.017**
Weight 77.9±12.5 79.5±10.5 75.3±12.7 79.2±10.7 85.1±13.6 0.058
Height 163.3±9.2 167.4±8.1 162.2±7.5 166.5±8.6 165.6±9.8 0.262
BMI 29.4±5.2 28.4±3.4 28.7±5.2 28.6±4.1 31.2±5.7 0.146
Met S 12 (40.0%) 13 (52.0%) 11 (68.8%) 13 (44.8%) 26 (76.5%) 0.021***
HT 16 (53.3%) 10 (40.0%) 11 (68.8%) 13 (44.8%) 25 (73.5%) 0.051
DM 6 (20.0%) 8 (32.0%) 6 (37.5%) 6 (20.7%) 17 (50.0%) 0.062
Glu (mg/dL) 92(78-300) 126(80-270) 130(80-300) 96(58-161) 115(63-280) <0.001
FH 10 (33.3%) 11 (44.0%) 6 (37.5%) 9 (31.0%) 7 (20.6%) 0.414
HPL 14 (46.7%) 11 (44.4%) 8 (50.0%) 13 (44.8%) 21 (61.8%) 0.612
Smoking 10 (33.3%) 16 (64.0%) 7 (43.8%) 16 (55.2%) 14 (41.2%) 0.167
EF (%) 67 (30-74) 42.5 (35-57) 47.5 (28-68) 66 (20-70) 66 (45-71) <0.001††
Hb (g/dL) 14.1±1.1 14.2±1.6 13.5±1.9 14.2±1.8 14.2±1.2 0.487
Ischemic ECG 7 (23%) 25 (100%) 8 (50%) 13 (44.8%) 6 (17.6%) <0.001

Basal characteristics of the study population. BMI: body mass index, Met S: metabolic syndrome, DM: diabetes mellitus, HT: hypertension, FH: family history of atherosclerotic coronary artery disease, EF: ejection fraction, Hb: hemoglobin, Glu: fasting blood glucose. For p values
* control-Non ST Elevation MI (NSTEMI)
** ST Elevation MI (STEMI) - NSTEMI
*** control-Stable Angina Pectoris (SAP)
control-STEMI/NSTEMI
†† control-STEMI/NSTEMI
control-STEMI/NSTEMI.